BRANDON HANSEN: Open Payments
NPI 1467735621 · RIVERTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,386 in 123 payments from 29 companies in 2025. Trend: 2023 $1,808 · 2024 $2,077 · 2025 $2,386
Food & beverage: $2,386
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $472 |
| Corcept Therapeutics | 8 | $205 |
| Lilly USA, LLC | 9 | $160 |
| AstraZeneca Pharmaceuticals LP | 6 | $156 |
| Abbott Laboratories | 3 | $152 |
| TerSera Therapeutics LLC | 4 | $124 |
| Collegium Pharmaceutical, Inc. | 6 | $101 |
| Lundbeck LLC | 5 | $96 |
| Phathom Pharmaceuticals, Inc. | 7 | $95 |
| Amgen Inc. | 6 | $91 |
Products named: VRAYLAR, Korlym, FREESTYLE LIBRE 3, FARXIGA, Quzyttir, UBRELVY, Jornay PM, MOUNJARO.
Industry payments across UT — which companies pay providers there.
